Renal angiomyolipomas (AML) are benign lesions usually left alone. However, lesions larger than 4 cm carry the risk of spontaneous haemorrhage and need treatment. Angiography and embolisation are the current standard of care particularly in patients with high operative risks. Angio-embolisation is a safe, minimally invasive procedure preserving maximum renal parenchyma, with the added advantage of preventing peri-procedural morbidity. Two cases of AML are presented in this case series.
Introduction
Renal angiomyolipomas (AML) are benign lesions usually left alone. However, lesions larger than 4 cm carry the risk of spontaneous haemorrhage and need treatment. Angiography and embolisation are the current standard of care particularly in patients with high operative risks. [1] [2] [3] We share two cases of AML presenting with peri-tumoral haemorrhage treated with angiography and embolisation.
Case Report

Case 1
A 59-year-old lady with multiple comorbidities (Diabetes, hypertension, prior history of cardiac valve surgery, CABG and pacemaker in situ) presented with left flank pain. Computed tomography showed a large left renal lower pole AML measuring 7 cm with a perirenal haematoma. After obtaining medical and cardiac fitness, antiplatelet and anticoagulant therapy was held to obtain normal coagulation status. Angiography demonstrated an ectatic aneurysmal segmental left renal artery supplying AML. Embolisation was performed using two vials of PVA particles (500-700 μ) through a 4 Fr C2 catheter.
Post-procedure angiogram demonstrated preserved left renal parenchyma without any flow into the AML.
[ Figure 1a -e] Patient had an uneventful recovery and anticoagulant therapy was reinstated the following day after the procedure [ Figures 1 and 2a -e].
Case 2
A 44-year-old lady with no comorbid presented with severe left flank pain followed by hypotension. She was resuscitated at an outside facility and workup showed a large right upper renal pole AML measuring 9 cm with large perirenal haematoma, small intraperitoneal haemorrhage and right pleural effusion. The AML was predominantly being supplied by a small branch arising directly from aorta adjacent to the superior mesenteric artery leading to multiple large aneurysmal dilatations within the AML [ Figure 3a -e].
It was engaged with 5 Fr SIM-2 catheter and 2.7 Fr microcatheter was then used to embolise the AML using a combination of three vials of PVA particles and five coils of various sizes. Post-procedure angiogram demonstrated 
Discussion
AMLs are benign mostly asymptomatic renal masses that are largely detected incidentally. Treatment is necessary for symptomatic patients or when the lesion size exceeds 4 cm. [4] The aim is to relieve symptoms and prevent haemorrhage, with the priority of preserving renal function. Treatment options include arterial embolisation or surgical excision. Angio-embolilsation carries the advantage of being minimally invasive, preservation of renal function and rapid haemodynamic stabilisation in settings of acute intra/peri-lesional haemorrhage. [3, 5] Optimal candidates for embolisation are tumours receiving blood supply by a single arterial branch. In tumours with complex vascular anatomy, embolisation of multiple branches is technically challenging with an increased risk of embolising adjoining normal renal parenchyma with potential functional compromise. [6, 7, 8] 
Conclusion
Embolisation of renal AML is a safe minimally invasive procedure preserving maximum renal parenchyma, with the added advantage of preventing peri-procedural morbidity. We recommend it as first-line treatment for all AML's requiring treatment.
